Risk Determinants of Acute Mountain Sickness and Summit Success on a 6-Day Ascent of Mount Kilimanjaro (5895 m).

Objective: The aims of this study were to assess incidence of acute mountain sickness (AMS) and summit success on a 6-day ascent profile of Mt. Kilimanjaro and evaluate potential risk factors for these outcomes.

Methods: All trekkers through a single Australian tour company between August 2012 and July 2014 were included.

Serum biochemistry and morbidity among runners presenting for medical care after an Australian mountain ultramarathon.

Objective: To determine if exercise-associated hyponatremia (EAH) was a cause of morbidity among runners requiring medical care at an Australian mountain ultramarathon.

Design: Case series.

Setting: Six Foot Track mountain ultramarathon, New South Wales, Australia, March 2006.

NSAID use increases the risk of developing hyponatremia during an Ironman triathlon.

Purpose: Exertional hyponatremia ((Na) < 135 mmol x L(-1)) is a potentially serious condition associated with endurance sports. It has been postulated that nonsteroidal antiinflammatory drug (NSAID) use may be a risk factor. This observational cohort study aimed to determine whether NSAID use is a risk factor for exertional hyponatremia and altered renal function during endurance exercise.

Study of hematological and biochemical parameters in runners completing a standard marathon.

Objective: To study hematological and biochemical parameters prospectively in runners completing a standard 42.2-km marathon run. To determine the incidence of hyponatremia in runners, and whether consumption of nonsteroidal anti-inflammatory medications (NSAIDs) was associated with alterations in serum biochemical parameters.